Letter by Reynolds Et Al Regarding Article, "Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial"
Circulation - United States
doi 10.1161/circulationaha.111.056077
Full Text
Open PDFAbstract
Available in full text
Date
January 24, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)